Warfarin in non-valvular atrial fibrillation
dc.contributor.author | Dalby, Anthony J | |
dc.contributor.author | Wessels, Pieter | |
dc.contributor.author | Opie, Lionel H | |
dc.date.accessioned | 2021-10-08T07:20:26Z | |
dc.date.available | 2021-10-08T07:20:26Z | |
dc.date.issued | 2013 | |
dc.description.abstract | The development of novel oral anticoagulants that are effective alternatives to warfarin in non-valvular atrial fibrillation (AF) is a welcome advance. However, a variety of unresolved problems with their use, and not least with their cost, make it important to re-evaluate the use of warfarin as it will likely remain the anticoagulant of choice in South African patients with non-valvular AF for the foreseeable future. In this article, we review the correct clinical use of warfarin. Guidance is provided on commencing warfarin treatment, maintenance dosing, the recommended steps when temporary withdrawal of treatment is necessary, the management of bleeding, and the use of warfarin in chronic kidney disease. Techniques for changing from warfarin to one of the new oral anticoagulants and vice versa are included. | |
dc.identifier.apacitation | Dalby, A. J., Wessels, P., & Opie, L. H. (2013). Warfarin in non-valvular atrial fibrillation. <i>South African Medical Journal</i>, 103(12), 901 - 177. http://hdl.handle.net/11427/34916 | en_ZA |
dc.identifier.chicagocitation | Dalby, Anthony J, Pieter Wessels, and Lionel H Opie "Warfarin in non-valvular atrial fibrillation." <i>South African Medical Journal</i> 103, 12. (2013): 901 - 177. http://hdl.handle.net/11427/34916 | en_ZA |
dc.identifier.citation | Dalby, A.J., Wessels, P. & Opie, L.H. 2013. Warfarin in non-valvular atrial fibrillation. <i>South African Medical Journal.</i> 103(12):901 - 177. http://hdl.handle.net/11427/34916 | en_ZA |
dc.identifier.issn | 0038-2469 | |
dc.identifier.ris | TY - Journal Article AU - Dalby, Anthony J AU - Wessels, Pieter AU - Opie, Lionel H AB - The development of novel oral anticoagulants that are effective alternatives to warfarin in non-valvular atrial fibrillation (AF) is a welcome advance. However, a variety of unresolved problems with their use, and not least with their cost, make it important to re-evaluate the use of warfarin as it will likely remain the anticoagulant of choice in South African patients with non-valvular AF for the foreseeable future. In this article, we review the correct clinical use of warfarin. Guidance is provided on commencing warfarin treatment, maintenance dosing, the recommended steps when temporary withdrawal of treatment is necessary, the management of bleeding, and the use of warfarin in chronic kidney disease. Techniques for changing from warfarin to one of the new oral anticoagulants and vice versa are included. DA - 2013 DB - OpenUCT DP - University of Cape Town IS - 12 J1 - South African Medical Journal LK - https://open.uct.ac.za PY - 2013 SM - 0038-2469 T1 - Warfarin in non-valvular atrial fibrillation TI - Warfarin in non-valvular atrial fibrillation UR - http://hdl.handle.net/11427/34916 ER - | en_ZA |
dc.identifier.uri | http://hdl.handle.net/11427/34916 | |
dc.identifier.vancouvercitation | Dalby AJ, Wessels P, Opie LH. Warfarin in non-valvular atrial fibrillation. South African Medical Journal. 2013;103(12):901 - 177. http://hdl.handle.net/11427/34916. | en_ZA |
dc.language.iso | eng | |
dc.publisher.department | Division of Cardiology | |
dc.publisher.faculty | Faculty of Health Sciences | |
dc.source | South African Medical Journal | |
dc.source.journalissue | 12 | |
dc.source.journalvolume | 103 | |
dc.source.pagination | 901 - 177 | |
dc.source.uri | https://dx.doi.org/10.7196/SAMJ.7172 | |
dc.subject.other | Administration, Oral | |
dc.subject.other | Anticoagulants | |
dc.subject.other | Atrial Fibrillation | |
dc.subject.other | Dose-Response Relationship, Drug | |
dc.subject.other | Drug Interactions | |
dc.subject.other | Drug Monitoring | |
dc.subject.other | Hemorrhage | |
dc.subject.other | Humans | |
dc.subject.other | Medication Therapy Management | |
dc.subject.other | Practice Guidelines as Topic | |
dc.subject.other | Stroke | |
dc.subject.other | Warfarin | |
dc.title | Warfarin in non-valvular atrial fibrillation | |
dc.type | Journal Article | |
uct.type.publication | Research | |
uct.type.resource | Journal Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- DalbyAnthonyJ_Warfarin_in_non_2013.pdf
- Size:
- 129.54 KB
- Format:
- Adobe Portable Document Format
- Description: